OPNT Opiant Pharmaceuticals Inc.

Opiant Pharmaceuticals Inc is a specialty pharmaceutical company. The Company develops opioid pharmacological treatments for substance use, addictive and eating disorders.

As of 10/03/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  5,164,151
Average volume:  13,639
Market cap:   $54,068,661
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -6.92
PB ratio:   1.39
PS ratio:   0.00
Return on equity:   -16.13%
Net income %:   -39.61%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy